Skip to content
Biopharma Boehringer Ingelheim took a big step toward achieving the company’s goal of carbon neutrality by 2030 with the July 8 inauguration of a […]
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint Read More »
In recognition of significant advancements in biotechnology’s impact on our food supply, the Biotechnology Innovation Organization (BIO) recently recognized industry leaders who helped drive
BIO honors innovators with 2024 Leadership in Agri-Biotechnology Awards Read More »
Immuto Scientific is opening new frontiers in the fight against cancer by developing precision biotherapeutics that target highly cancer-specific surface protein conformations. Their ultimate
NIH Innovation Zone 2024: Immuto Scientific identifies new cancer targets Read More »
The Centers for Disease Prevention and Control (CDC) recently issued new recommendations to enhance preparedness for the upcoming respiratory virus season. These guidelines focus
CDC issues new guidelines to prepare for respiratory virus season Read More »
Talus Bio’s collaborative and innovative approach to unlocking the therapeutic potential of targeting transcription factors for cancer and other diseases is putting them at
As 2024 Pride Month concludes, the biotech industry reflects on the critical importance of LGBTQ+ representation and the ongoing efforts to foster inclusivity. The
Pride Month 2024: LGBTQ+ biotech leaders celebrate progress, recognize gaps Read More »
John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), highlighted the crucial themes of “innovation, access, and advocacy” during his keynote
Injecting medicine can be a scary prospect. It is not just the fear of needles that can prevent patients from self-administration. Even traditional auto-injector
NIH Innovation Zone 2024: Pirouette Medical is innovating safer, easier auto-injections Read More »
A bill to reauthorize a program that encourages the development of pediatric rare disease treatments was introduced in the Senate on June 20. Bill
Pediatric Priority Review Voucher reauthorization introduced in Senate Read More »
“ALS is a devastating disease.” This is a common refrain when talking about Amyotrophic Lateral Sclerosis (ALS), a nervous system disease that weakens muscles
Unlocking hope: AMP ALS is transforming ALS biomarker research Read More »
